Nymble Health empowers patients to take charge of their health journey through trusted, seamless communication. As a simple contact on your phone, Nymble offers real-time, clinically-backed support programs designed to help patients stay informed and engaged in their care. Using AI, Nymble provides a steady flow of personalized, relevant health insights that meet patients where they are, on the platforms they prefer—whether via iMessage, Android RCS, or WhatsApp.
Our flagship program focuses on patients managing obesity with GLP-1 medications, developed in collaboration with global leaders in obesity medicine, including the authors of international obesity guidelines. With Nymble, patients gain access to expert-driven guidance and support tailored to their needs, empowering them to navigate treatment confidently and effectively.
Founder and CEO
Head of Strategy and Operations
Obesity Medicine Advisor
CTO
Southern Ontario Pharmaceutical & Health Innovation Ecosystem (SOPHIE) Program brings together Innovation Factory’s commercialization services with the Synapse Life Science Consortium’s strategic network to leverage access to Hamilton’s unique life sciences capabilities and research expertise.